New Factor XI inhibitor shows superior safety in treating atrial fibrillation

Stiinta si Tehnologie

Mass General Brigham Jan 22 2025 Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to concerns of increased risk of bleeding complications. Researchers from Mass General Brigham evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The

din zilele anterioare